BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

Abstract Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (BAFF) may be playing a role in the development of immunogenicity. The objective of...

Full description

Saved in:
Bibliographic Details
Main Authors: Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E. Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J. Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/23161f74c66b452fadeaadcaeff92d76
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/23161f74c66b452fadeaadcaeff92d76

Similar Items